| Nutlin-3a |
ENSG00000088970.11 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000117242.7 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000142396.6 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000146666.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000153363.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000157152.12 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000172965.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000172965.10 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000175772.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000177406.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000177640.11 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000178193.5 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000178440.5 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000178977.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000179219.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000179818.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000179818.9 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000180422.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000180846.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000181097.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000182057.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000182057.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000182310.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000182366.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000182873.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000183242.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000184274.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000185168.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000185433.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000185904.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000186019.10 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000186148.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000186615.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000187904.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000188365.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000189149.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000189223.9 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000189238.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000196553.9 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000196553.9 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000196559.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000196668.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000196756.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000196810.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000196951.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000197332.7 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000197813.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000203280.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000203288.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000203288.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000203327.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000203327.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000203441.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000203441.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000203496.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000203496.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000203496.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000203593.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000203650.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000203650.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000203706.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000203706.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000203709.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000203721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000203721.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000203808.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000203849.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000203849.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000204044.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000204588.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000204625.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000204706.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000204792.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000204792.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000204815.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000204815.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000204860.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000205056.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000205181.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000205488.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000205611.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000205611.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000205662.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000205913.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000205913.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000205959.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000206028.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000206129.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000206129.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000206129.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000206417.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000206567.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000212978.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000212978.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000213742.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000213793.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000213863.2 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000213994.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000213994.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000214347.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000214401.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000214401.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000214407.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000214650.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000214650.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000214773.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000214803.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000214870.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000214922.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000214955.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000215244.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000215244.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000215417.6 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000215447.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000215447.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000215483.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000215692.2 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000215769.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000217576.7 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000218018.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000222041.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000222041.6 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000222043.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000222044.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000223374.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000223379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000223382.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000223387.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000223396.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000223522.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000223528.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000223542.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000223576.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000223660.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000223692.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000223695.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000223695.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000223695.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000223711.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000223725.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000223727.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000223749.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000223768.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000223791.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000223797.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000223834.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000223839.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000223839.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000223842.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000223882.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000223891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000223901.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000223949.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000223949.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000223969.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000223975.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000224063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000224078.8 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000224078.8 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000224099.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000224101.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000224142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000224142.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000224174.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000224184.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000224292.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000224292.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000224310.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000224356.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000224356.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000224490.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000224533.3 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000224533.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000224536.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000224609.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000224687.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000224691.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000224698.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000224707.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000224745.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000224789.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000224789.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000224805.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000224818.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000224818.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000224818.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000224843.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000224843.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000224855.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000224888.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000224897.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000224939.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000224959.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000224959.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000224969.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000224975.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000224975.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000224992.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000225030.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000225037.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000225076.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000225077.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000225106.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000225146.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000225152.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000225172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000225173.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000225205.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000225218.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000225265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000225302.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000225313.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000225315.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000225353.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000225383.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000225420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000225434.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000225434.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000225439.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000225442.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000225489.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000225490.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000225498.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000225506.2 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000225527.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000225541.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000225546.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000225611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000225684.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000225703.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000225725.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000225745.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000225778.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000225783.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000225790.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000225806.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000225822.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000225839.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000225839.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000225891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000225905.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000225913.2 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000225945.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000225945.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000225973.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000225975.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000225978.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000226009.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000226047.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000226047.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000226047.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000226089.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000226115.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000226137.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000226179.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000226179.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000226245.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000226272.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000226328.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000226332.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000226367.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000226380.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000226445.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000226526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000226598.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000226629.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000226659.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000226690.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000226696.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000226752.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000226758.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000226772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000226785.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000226786.2 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000226833.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000226851.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000226856.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000226859.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000226864.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000226877.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000226877.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000226900.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000226917.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000226950.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000226965.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000227006.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000227014.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000227017.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000227060.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000227071.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000227213.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000227214.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000227218.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000227218.3 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000227227.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000227237.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000227245.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000227355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000227359.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000227372.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000227372.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000227375.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000227388.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000227388.2 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000227400.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000227409.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000227456.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000227492.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000227496.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000227527.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000227543.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000227544.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000227552.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000227574.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000227589.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000227617.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000227637.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000227637.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000227676.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000227698.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000227719.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000227719.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000227733.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000227741.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000227741.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000227848.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000227888.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000227896.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000227906.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000227946.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000227954.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000228010.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000228065.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000228079.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000228086.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000228113.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000228113.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000228124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000228137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000228137.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000228140.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000228192.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000228201.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000228265.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000228271.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000228322.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000228323.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000228323.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000228327.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000228352.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000228389.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000228395.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000228427.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000228436.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000228437.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000228452.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000228486.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000228487.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000228487.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000228526.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000228536.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000228540.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000228544.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000228604.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000228649.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000228677.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000228692.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000228701.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000228705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000228784.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000228786.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000228802.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000228817.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000228838.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000228839.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000228878.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000228989.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000229065.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000229065.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000229081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000229081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000229118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000229122.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000229127.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000229178.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000229180.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000229190.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000229245.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000229267.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000229312.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000229325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000229325.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000229327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000229331.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000229388.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000229431.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000229444.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000229487.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000229498.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000229502.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000229558.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000229591.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000229591.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000229645.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000229647.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000229656.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000229688.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000229697.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000229728.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000229867.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000229896.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000229901.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000229901.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000229915.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000229989.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000229999.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000230013.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000230013.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000230020.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000230021.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000230024.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000230054.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000230068.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000230074.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000230084.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000230109.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000230140.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000230186.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000230257.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000230289.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000230290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000230337.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000230337.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000230408.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000230454.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000230461.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000230470.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000230506.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000230513.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000230513.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000230526.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000230537.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000230542.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000230555.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000230555.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000230555.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000230565.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000230565.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000230612.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000230641.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000230679.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000230699.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000230724.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000230725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000230751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000230753.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000230753.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000230806.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000230812.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000230826.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000230836.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000230896.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000230912.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000231024.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000231025.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000231028.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000231073.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000231102.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000231104.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000231193.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000231231.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000231242.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000231290.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000231290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000231294.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000231305.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000231305.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000231329.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000231329.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000231393.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000231485.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000231486.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000231512.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000231527.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000231528.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000231563.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000231616.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000231616.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000231636.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000231646.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000231651.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000231652.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000231690.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000231705.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000231711.2 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000231764.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000231769.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000231774.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000231789.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000231871.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000231881.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000231890.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000231903.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000231948.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000231976.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000231977.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000231993.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000232063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000232065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000232085.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000232116.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000232118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000232118.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000232131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000232131.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000232160.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000232274.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000232274.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000232290.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000232298.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000232311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000232336.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000232352.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000232354.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000232363.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000232485.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000232500.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000232504.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000232533.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000232613.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000232618.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000232623.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000232648.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000232677.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000232677.2 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000232686.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000232692.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000232725.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000232732.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000232811.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000232860.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000232900.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000232909.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000232912.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000232912.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000232956.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000232969.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000232969.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000233013.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000233033.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000233058.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000233058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000233144.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000233203.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000233242.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000233242.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000233244.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000233244.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000233250.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000233251.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000233396.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000233397.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000233427.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000233452.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000233461.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000233483.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000233483.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000233509.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000233527.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000233527.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000233547.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000233559.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000233602.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000233621.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000233672.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000233757.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000233806.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000233806.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000233806.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000233825.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000233862.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000233862.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000233885.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000233895.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000233895.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000233901.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000233901.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000233926.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000233967.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000234084.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000234147.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000234185.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000234233.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000234264.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000234281.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000234286.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000234290.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000234311.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000234327.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000234350.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000234393.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000234405.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000234428.2 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000234459.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000234494.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000234546.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000234546.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000234571.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000234630.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000234665.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000234678.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000234684.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000234694.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000234753.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000234771.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000234772.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000234789.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000234793.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000234817.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000234828.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000234848.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000234871.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000234915.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000234917.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000234945.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000234996.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000235029.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000235051.3 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000235078.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000235085.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000235096.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000235106.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000235117.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000235117.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000235119.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000235121.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000235131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000235138.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000235146.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000235214.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000235257.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000235257.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000235280.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000235358.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000235373.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000235397.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000235397.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000235448.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000235448.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000235475.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000235477.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000235522.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000235527.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000235545.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000235586.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000235635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000235659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000235663.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000235706.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000235823.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000235843.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000235852.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000235890.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000235903.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000235910.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000236017.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000236065.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000236065.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000236065.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000236066.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000236091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000236098.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000236098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000236188.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000236194.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000236194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000236199.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000236200.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000236204.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000236266.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000236266.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000236318.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000236352.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000236463.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000236472.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000236514.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000236514.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000236526.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000236528.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000236528.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000236537.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000236559.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000236559.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000236581.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000236591.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000236591.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000236601.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000236643.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000236651.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000236751.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000236753.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000236754.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000236772.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000236778.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000236778.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000236799.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000236846.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000236850.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000236859.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000236901.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000236914.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000236924.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000236943.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000236953.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000236977.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000236986.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000236991.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000237015.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000237037.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000237061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000237094.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000237126.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000237126.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000237149.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000237152.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000237166.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000237222.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000237250.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000237253.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000237253.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000237253.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000237291.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000237298.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000237301.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000237301.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000237356.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000237371.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000237399.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000237402.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000237436.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000237505.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000237513.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000237595.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000237664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000237738.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000237738.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000237738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000237741.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000237838.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000237852.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000237870.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000237883.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000237886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000237975.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000237976.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000238033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000238068.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000238120.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000238121.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000238122.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000238123.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000238133.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000238140.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000238141.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000238142.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000238178.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000238197.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000238197.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000238198.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000238210.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000238261.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000238272.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000238273.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000238280.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000239219.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000239300.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000239552.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000239593.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000239674.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000239705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000239705.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000239705.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000239828.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000239906.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000239911.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000240032.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000240057.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000240207.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000240211.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000240254.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000240350.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000240373.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000240401.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000240497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000240498.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000240541.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000240549.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000240553.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000240571.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000240618.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000240687.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000240758.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000240758.2 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000240770.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000240790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000240859.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000240875.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000240915.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000240996.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000241155.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000241155.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000241180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000241219.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000241269.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000241269.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000241317.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000241388.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000241560.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000241720.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000241769.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000241860.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000242094.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000242154.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000242282.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000242349.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000242391.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000242396.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000242516.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000242516.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000242578.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000242578.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000242622.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000242759.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000242781.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000242791.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000242798.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000242861.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000242861.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000242861.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000242925.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000243018.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000243107.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000243296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000243433.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000243433.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000243433.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000243485.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000243533.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000243533.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000243629.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000243629.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000243701.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000243701.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000243797.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000243819.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000243849.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000243849.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000243926.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000243967.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000244063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000244184.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000244349.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000244380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000244380.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000244479.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000244513.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000244586.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000244625.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000244675.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000244676.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000244738.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000244926.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000245112.2 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000245213.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000245248.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000245322.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000245498.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000245526.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000245532.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000245532.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000245534.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000245552.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000245573.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000245614.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000245711.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000245750.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000245849.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000245904.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000245904.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000246100.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000246145.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000246225.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000246250.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000246263.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000246308.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000246695.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000246777.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000246863.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000246898.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000246898.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000246982.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000247095.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000247134.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000247151.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000247193.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000247199.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000247271.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000247324.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000247363.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000247516.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000247624.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000247624.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000247675.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000247735.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000247796.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000247809.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000248008.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000248027.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000248092.3 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000248125.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000248161.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000248223.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000248254.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000248268.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000248356.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000248360.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000248367.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000248399.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000248475.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000248476.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000248479.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000248515.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000248559.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000248698.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000248714.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000248719.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000248724.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000248740.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000248740.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000248858.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000248859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000248890.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000248925.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000248932.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000248980.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000249028.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000249042.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000249082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000249084.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000249096.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000249198.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000249258.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000249293.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000249306.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000249375.3 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000249409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000249417.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000249430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000249451.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000249483.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000249534.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000249572.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000249595.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000249602.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000249602.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000249609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000249623.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000249635.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000249635.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000249664.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000249664.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000249685.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000249787.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000249816.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000249898.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000249911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000249955.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000249955.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000250049.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000250061.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000250061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000250069.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000250069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000250073.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000250075.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000250081.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000250081.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000250101.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000250107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000250122.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000250122.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000250131.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000250208.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000250220.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000250230.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000250240.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000250260.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000250303.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000250303.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000250337.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000250362.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000250397.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000250397.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000250404.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000250404.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000250451.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000250490.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000250509.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000250602.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000250608.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000250608.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000250635.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000250635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000250659.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000250820.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000250893.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000250900.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000250903.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000250917.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000250988.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000251023.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000251023.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000251026.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000251034.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000251093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000251095.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000251095.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000251136.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000251148.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000251175.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000251175.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000251179.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000251292.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000251298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000251307.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000251323.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000251323.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000251323.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000251331.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000251396.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000251455.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000251523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000251603.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000251613.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000251661.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000251666.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000251867.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000253106.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000253121.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000253197.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000253263.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000253327.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000253390.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000253398.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000253476.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000253535.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000253552.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000253608.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000253616.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000253641.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000253669.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000253678.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000253687.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000253696.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000253708.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000253730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000253737.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000253819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000253852.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000253878.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000253929.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000253931.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000253944.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000253955.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000253955.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000253965.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000254003.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000254028.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000254057.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000254060.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000254101.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000254109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000254111.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000254144.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000254162.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000254162.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000254177.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000254186.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000254192.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000254207.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000254208.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000254224.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000254300.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000254338.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000254343.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000254369.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000254419.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000254419.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000254428.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000254428.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000254431.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000254433.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000254551.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000254577.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000254577.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000254604.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000254610.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000254620.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000254635.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000254639.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000254639.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000254664.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000254691.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000254694.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000254694.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000254762.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000254812.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000254833.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000254837.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000254854.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000254859.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000254907.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000254910.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000254934.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000254985.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000254987.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000254990.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000255045.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000255050.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000255089.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000255089.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000255090.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000255100.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000255120.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000255135.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000255145.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000255158.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000255165.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000255182.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000255201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000255202.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000255334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000255337.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000255343.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000255355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000255355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000255382.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000255409.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000255418.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000255418.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000255435.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000255447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000255449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000255458.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000255471.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000255520.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000255545.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000255571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000255621.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000255669.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000255843.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000255847.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000255847.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000255856.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000255929.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000255933.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000255983.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000256011.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000256050.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000256128.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000256271.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000256325.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000256417.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000256433.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000256448.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000256546.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000256576.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000256603.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000256712.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000256742.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000256802.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000256824.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000256894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000256967.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000257004.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000257023.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000257058.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000257097.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000257151.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000257167.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000257167.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000257176.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000257191.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000257252.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000257252.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000257264.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000257270.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000257279.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000257283.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000257283.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000257354.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000257381.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000257391.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000257433.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000257496.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000257497.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000257534.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000257557.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000257613.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000257621.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000257642.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000257647.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000257696.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000257702.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000257702.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000257725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000257735.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000257742.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000257769.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000257769.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000257809.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000257809.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000257815.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000257829.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000257877.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000257883.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000257886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000257910.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000257953.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000257999.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000258001.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000258086.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000258088.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000258199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000258249.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000258260.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000258260.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000258274.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000258285.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000258301.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000258303.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000258303.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000258314.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000258337.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000258390.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000258413.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000258424.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000258424.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000258441.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000258454.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000258558.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000258558.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000258558.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000258569.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000258642.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000258661.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000258682.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000258711.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000258736.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000258748.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000258821.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000258827.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000258851.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000258858.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000258884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000258904.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000258946.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000258957.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000258957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000259006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000259065.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000259065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000259081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000259129.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000259138.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000259146.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000259163.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000259209.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000259209.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000259212.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000259215.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000259234.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000259238.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000259241.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000259244.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000259250.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000259278.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000259287.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000259298.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000259306.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000259319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000259322.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000259343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000259353.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000259364.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000259365.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000259365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000259398.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000259398.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000259402.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000259408.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000259426.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000259439.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000259442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000259450.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000259450.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000259474.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000259523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000259551.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000259553.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000259561.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000259583.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000259583.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000259584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000259589.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000259595.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000259606.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000259617.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000259654.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000259678.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000259705.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000259715.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000259717.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000259721.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000259732.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000259768.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000259768.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000259774.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000259783.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000259788.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000259804.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000259810.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000259818.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000259876.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000259878.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000259884.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000259935.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000259953.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000259967.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000260000.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000260017.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000260022.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000260046.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000260051.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000260051.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000260051.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000260059.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000260060.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000260060.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000260063.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000260086.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000260093.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000260123.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000260141.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000260156.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000260156.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000260167.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000260176.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000260186.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000260194.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000260219.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000260228.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000260257.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000260273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000260277.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000260278.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000260316.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000260329.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000260329.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000260360.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000260367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000260394.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000260404.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000260447.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000260447.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000260479.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000260493.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000260495.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000260528.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000260536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000260541.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000260565.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000260578.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000260588.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000260591.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000260601.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000260604.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000260608.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000260608.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000260614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000260618.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000260635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000260637.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000260637.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000260641.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000260641.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000260646.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000260646.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000260660.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000260693.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000260693.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000260708.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000260725.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000260742.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000260742.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000260744.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000260750.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000260766.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000260774.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000260796.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000260805.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000260805.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000260816.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000260830.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000260874.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000260895.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000260896.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000260896.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000260936.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000260936.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000260936.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000260954.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000260976.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000260988.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000261008.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000261015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000261019.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000261026.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000261051.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000261064.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000261069.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000261083.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000261101.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000261114.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000261124.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000261135.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000261135.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000261159.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000261167.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000261167.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000261167.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000261172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000261173.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000261186.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000261189.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000261200.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000261207.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000261211.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000261216.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000261216.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000261235.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000261242.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000261242.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000261251.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000261267.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000261267.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000261288.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000261296.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000261302.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000261324.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000261324.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000261353.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000261355.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000261357.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000261366.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000261379.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000261394.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000261396.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000261396.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000261396.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000261416.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000261420.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000261428.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000261430.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000261433.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000261437.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000261442.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000261451.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000261468.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000261469.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000261476.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000261533.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000261550.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000261550.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000261597.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000261613.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000261618.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000261630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000261632.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000261646.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000261654.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000261655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000261662.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000261695.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000261706.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000261723.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000261723.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000261737.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000261737.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000261744.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000261760.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000261766.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000261775.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000261786.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000261801.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000261842.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000261889.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000261916.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000262094.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000262117.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000262147.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000262152.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000262171.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000262185.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000262194.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000262222.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000262223.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000262223.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000262298.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000262312.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000262370.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000262372.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000262412.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000262482.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000262514.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000262558.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000262652.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000262678.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000262678.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000262681.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000262686.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000262777.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000262823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000262877.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000262881.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000262888.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000262920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000262952.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000262973.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000263004.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000263013.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000263050.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000263080.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000263082.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000263098.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000263120.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000263167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000263214.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000263220.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000263350.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000263470.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000263499.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000263603.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000263657.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000263727.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000263786.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000263786.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000263847.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000263916.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000263924.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000263924.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000264043.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000264107.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000264107.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000264188.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000264207.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000264290.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000264304.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000264304.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000264448.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000264456.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000264456.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000264548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000264569.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000264630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000264630.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000264745.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000264808.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000264812.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000264895.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000264920.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000264964.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000265205.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000265222.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000265242.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000265282.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000265282.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000265342.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000265399.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000265474.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000265478.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000265479.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000265485.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000265490.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000265490.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000265533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000265778.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000265791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000265800.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000265845.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000265888.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000265907.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000265912.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000266079.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000266114.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000266289.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000266313.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000266445.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000266446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000266456.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000266473.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000266677.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000266709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000266835.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000266850.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000266850.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000266896.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000266897.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000266903.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000266904.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000266913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000266921.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000266921.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000266921.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000266922.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000266926.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000266926.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000266930.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000266934.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000266935.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000266936.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000266936.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000266942.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000266942.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000266970.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000266970.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000266987.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000266987.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000266999.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000267002.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000267003.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000267003.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000267006.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000267011.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000267025.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000267026.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000267040.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000267044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000267058.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000267065.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000267065.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000267073.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000267093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000267096.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000267118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000267123.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000267128.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000267143.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000267143.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000267169.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000267221.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000267244.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000267246.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000267255.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000267262.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000267278.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000267279.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000267280.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000267282.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000267288.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000267299.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000267321.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000267327.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000267347.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000267390.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000267397.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000267412.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000267419.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000267446.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000267449.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000267470.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000267475.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000267479.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000267481.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000267481.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000267498.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000267498.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000267503.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000267530.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000267547.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000267560.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000267575.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000267581.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000267582.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000267649.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000267662.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000267667.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000267682.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000267701.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000267705.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000267737.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000267749.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000267750.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000267751.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000267758.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000267758.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000267766.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000267776.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000267783.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000267783.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000267785.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000267785.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000267786.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000267787.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000267834.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000267858.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000267874.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000267904.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000267905.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000267927.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000267939.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000268006.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000268006.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000268047.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000268047.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000268066.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000268201.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000268201.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000268201.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000268230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000268289.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000268316.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000268364.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000268366.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000268388.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000268392.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000268499.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000268516.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000268543.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000268555.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000268583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000268601.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000268615.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000268746.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000268756.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000268764.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000268873.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000268895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000268912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000268913.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000268931.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000268970.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000269051.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000269051.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000269066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000269091.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000269107.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000269148.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000269352.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000269392.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000269397.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000269427.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000269463.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000269463.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000269481.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000269487.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000269489.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000269534.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000269560.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000269560.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000269574.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000269600.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000269640.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000269646.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000269653.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000269653.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000269688.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000269688.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000269737.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000269737.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000269737.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000269806.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000269896.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000269899.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000269901.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000269903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000269921.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000269924.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000269934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000269944.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000269949.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000269956.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000269956.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000269959.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000269967.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000269971.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000269976.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000269980.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000269989.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000269997.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000269997.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000269997.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000270002.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000270012.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000270015.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000270030.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000270035.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000270048.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000270060.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000270081.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000270110.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000270120.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000270130.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000270140.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000270157.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000270164.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000270178.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000270178.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000270182.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000270190.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000270195.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000270210.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000270223.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000270237.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000270237.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000270346.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000270426.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000270462.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000270562.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000270571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000270599.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000270599.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000270605.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000270607.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000270640.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000270659.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000270726.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000270726.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000270761.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000270964.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000270996.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000270996.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000270996.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000271133.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000271133.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000271192.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000271199.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000271252.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000271314.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000271327.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000271327.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000271344.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000271382.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000271382.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000271384.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000271398.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000271398.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000271420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000271430.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000271430.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000271533.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000271533.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000271576.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000271727.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000271732.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000271734.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000271734.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000271738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000271743.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000271755.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000271782.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000271816.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000271825.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000271840.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000271851.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000271856.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000271856.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000271857.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000271874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000271912.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000271914.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000271927.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000271930.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000271931.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000271931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000271948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000271963.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000271963.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000271967.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000271971.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000271978.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000271983.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272004.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000272005.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000272005.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000272009.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000272023.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000272024.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272048.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272085.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000272087.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000272088.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000272088.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000272091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000272092.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000272093.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000272102.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000272102.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000272103.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272112.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272112.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000272112.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272121.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272128.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000272137.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000272137.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000272137.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000272140.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000272140.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000272142.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272142.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000272144.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000272161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000272168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272181.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000272183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000272192.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000272198.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000272198.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272198.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000272198.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000272216.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000272217.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000272219.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000272225.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000272233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272240.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272250.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000272254.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000272254.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000272273.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000272282.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000272301.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000272320.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000272334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272338.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000272343.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000272354.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000272354.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272365.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272374.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000272375.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000272377.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000272420.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000272420.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000272430.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000272432.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272438.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272457.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000272459.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000272462.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000272465.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000272482.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000272489.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000272489.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000272489.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000272524.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000272537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272568.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000272574.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000272604.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000272631.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000272650.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000272650.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000272657.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000272667.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000272668.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000272677.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000272688.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000272689.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000272690.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000272691.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000272695.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000272695.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000272699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272707.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000272707.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000272709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000272719.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000272734.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000272735.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000272755.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000272761.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000272761.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000272763.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000272763.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000272792.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000272795.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000272810.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000272812.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000272846.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000272858.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000272859.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000272894.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000272931.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000272954.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000272966.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000272966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000272983.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000273000.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000273011.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000273011.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000273017.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000273019.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000273027.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000273038.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000273038.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000273056.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000273058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000273066.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000273073.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000273077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000273084.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000273107.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000273107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000273107.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000273112.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000273118.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Nutlin-3a |
ENSG00000273125.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000273133.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000273139.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000273142.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000273145.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000273153.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000273156.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nutlin-3a |
ENSG00000273174.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000273175.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000273183.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Nutlin-3a |
ENSG00000273186.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000273188.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000273188.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000273237.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000273247.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000273253.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000273270.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000273297.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000273301.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000273308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000273308.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000273308.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000273325.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000273328.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
ENSG00000273335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000273335.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000273353.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nutlin-3a |
ENSG00000273356.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000273369.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nutlin-3a |
ENSG00000273374.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000273381.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000273381.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000273406.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nutlin-3a |
ENSG00000273406.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000273437.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nutlin-3a |
ENSG00000273445.1 |
Predicted lncRNA |
Sarcoma |
|
| Nutlin-3a |
ENSG00000273447.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Nutlin-3a |
ENSG00000273448.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Nutlin-3a |
ENSG00000273451.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nutlin-3a |
ENSG00000273473.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Nutlin-3a |
ENSG00000273481.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nutlin-3a |
ENSG00000273486.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nutlin-3a |
ENSG00000273493.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nutlin-3a |
GAS5-AS1 |
Curated lncRNA |
prostate cancer |
|
